Two new RCTs of rituximab will soon begin in the United Kingdom: A biomarker-based trial with add-on belimumab and another in ...

At univariable analysis, both anti-C1q antibodies and non-use of hydroxychloroquine predicted renal flares at baseline and 6 and 12 months. Proteinuria (24/h proteinuria and proteinuria 0.5 g/day or ...

May kicks off Lupus awareness month during which sufferers of the illness, and their supporters, wear purple or butterflies ...

Immunological testing was performed for C3 and C4 complement fractions, anti-double-stranded DNA, and anti-C1q antibodies. In proliferative lupus nephritis, anti-DNA and anti-C1q antibodies were ...

Investigators assessed the frequency of lupus flares in patients with kidney failure undergoing dialysis or with a kidney transplant.

Q1 2025 Earnings Call Transcript May 9, 2025 Kymera Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.82, expectations were $-0.92. Justine Koenigsberg: Good morning, and welcome to ...

Integra Therapeutics, a global leader in creating cutting-edge gene-writing tools to improve the efficacy, precision and ...

Although some biologists have since poured cold water on the actual science behind the dire wolf’s revival, there’s now talk ...

The kissing disease affects 90% of adults and could explain your fatigue and brain fog. Discover how Epstein-Barr virus might ...

FREDERICK, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the "Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, ...

The man scheduled for execution this month in Tennessee has declined to choose an execution method, which is what stopped ...